• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉瘤性蛛网膜下腔出血患者医疗并发症管理的建议

Recommendations for the management of medical complications in patients following aneurysmal subarachnoid hemorrhage.

作者信息

Solter Vesna Vargek, Roje-Bedeković Marina, Breitenfeld Tomislav, Supanc Visnja, Lovrencić-Huzjan Arijana, Serić Vesna, Antoncić Igor, Basić Silvio, Beros Vili, Bielen Ivan, Soldo Silva Butković, Kadojić Dragutin, Lusić Ivo, Maldini Branka, Marović Anton, Paladino Josip, Poljaković Zdravka, Radanović Branko, Rados Marko, Rotim Kresimir, Vukić Miroslav, Zadravec Dijana, Kes Vanja Basić

出版信息

Acta Clin Croat. 2014 Mar;53(1):113-38.

PMID:24974675
Abstract

These are evidence based guidelines for the management of medical complications in patients following aneurysmal subarachnoid hemorrhage, developed and endorsed by the Croatian Society of Neurovascular Disorders, Croatian Society of Neurology including Section for Neurocritical Care, Croatian Neurosurgical Society, Croatian Society for Difficult Airway Management and Croatian Medical Association. They consist of recommendations for best monitoring, medical treatment and interventions based on the literature, evaluation of the results of large international clinical trials, and collective experience of the authors.

摘要

这些是关于动脉瘤性蛛网膜下腔出血患者医疗并发症管理的循证指南,由克罗地亚神经血管疾病学会、克罗地亚神经病学学会(包括神经重症监护科)、克罗地亚神经外科学会、克罗地亚困难气道管理学会和克罗地亚医学协会制定并认可。它们包括基于文献、大型国际临床试验结果评估以及作者集体经验的最佳监测、医学治疗和干预建议。

相似文献

1
Recommendations for the management of medical complications in patients following aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血患者医疗并发症管理的建议
Acta Clin Croat. 2014 Mar;53(1):113-38.
2
General recommendations for the management of aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血管理的一般建议。
Acta Clin Croat. 2014 Mar;53(1):139-52.
3
Aneurysmal Subarachnoid Hemorrhage: Unanswered Questions.动脉瘤性蛛网膜下腔出血:未解决的问题。
Neurosurg Clin N Am. 2018 Apr;29(2):255-262. doi: 10.1016/j.nec.2018.01.001.
4
Aneurysmal subarachnoid hemorrhage: an overview for the practicing neurologist.颅内动脉瘤性蛛网膜下腔出血:神经科医生的实用概述。
Semin Neurol. 2010 Nov;30(5):545-54. doi: 10.1055/s-0030-1268862. Epub 2011 Jan 4.
5
Complications and follow up of subarachnoid hemorrhages.蛛网膜下腔出血的并发症和随访。
Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):677-86. doi: 10.1016/j.diii.2015.05.006. Epub 2015 Jun 26.
6
[Secondary complications of acute subarachnoid hemorrhage].[急性蛛网膜下腔出血的继发性并发症]
Radiologe. 2011 Feb;51(2):120-5. doi: 10.1007/s00117-010-2051-4.
7
Evidenced Based Guidelines for the Management of Good Grade Subarachnoid Haemorrhage Patients in Leeds, UK.英国利兹市良好分级蛛网膜下腔出血患者管理的循证指南
Acta Neurochir Suppl. 2011;110(Pt 2):161-4. doi: 10.1007/978-3-7091-0356-2_29.
8
Current and future treatment considerations in the management of aneurysmal subarachnoid hemorrhage.颅内动脉瘤性蛛网膜下腔出血管理中的当前及未来治疗考量
J Pharm Pract. 2010 Oct;23(5):408-24. doi: 10.1177/0897190010372334. Epub 2010 Aug 12.
9
[Diagnosis and treatment of subarachnoid hemorrhage].[蛛网膜下腔出血的诊断与治疗]
Rev Invest Clin. 2002 May-Jun;54(3):281-4.
10
Lumbar drainage after subarachnoid hemorrhage: does it reduce vasospasm and delayed hydrocephalus?蛛网膜下腔出血后腰椎引流:它能减少血管痉挛和迟发性脑积水吗?
Neurocrit Care. 2007;7(1):1-2. doi: 10.1007/s12028-007-0046-4.

引用本文的文献

1
Clinical Potential of Immunotherapies in Subarachnoid Hemorrhage Treatment: Mechanistic Dissection of Innate and Adaptive Immune Responses.免疫疗法在蛛网膜下腔出血治疗中的临床潜力:先天免疫和适应性免疫反应的机制剖析
Aging Dis. 2023 Oct 1;14(5):1533-1554. doi: 10.14336/AD.2023.0126.
2
Effect of early stellate ganglion block in cerebral vasospasm after aneurysmal subarachnoid hemorrhage (BLOCK-CVS): study protocol for a randomized controlled trial.早期星状神经节阻滞对动脉瘤性蛛网膜下腔出血后脑血管痉挛的影响(BLOCK-CVS):一项随机对照试验的研究方案。
Trials. 2022 Nov 4;23(1):922. doi: 10.1186/s13063-022-06867-9.
3
Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society.
神经危重症临床绩效评估指标:神经重症监护学会医疗专业人员立场声明。
Neurocrit Care. 2020 Feb;32(1):5-79. doi: 10.1007/s12028-019-00846-w.